BEUDAMED
    FDA Adverse Event Death Summary report: N

    EUFLEXXA 20 MG/2 ML (6=3 SYR)

    MDR report key: 22493469 · Received July 14, 2025

    Report

    Report Number
    MW5172541
    Event Type
    Death
    Date Received
    July 14, 2025
    Date of Event
    June 26, 2025
    Report Date
    July 8, 2025
    Manufacturer
    FERRING PHARMACEUTICALS INC.
    Product Code
    MOZ
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    PA, US
    Reporter Occupation
    PHARMACIST
    Health Professional
    N

    Narratives

    Description of Event or Problem · 0

    CAREGIVER REPORTED THAT THE PT PASSED AWAY ON (B)(6) 2025. FREQ: INJECT 1 SYRINGE INTRA-ARTICULARLY INTO RIGHT KNEE EVERY WEEK FOR 3 WEEKS. PRESCRIBER INFO: (B)(6).

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1046684 EUFLEXXA 20 MG/2 ML (6=3 SYR) ACID, HYALURONIC, INTRAARTICULAR MOZ FERRING PHARMACEUTICALS INC. X10511A

    Patients

    Seq Age Sex Outcome Treatment
    1 83 YR Male Death ALBUTEROL AER HFA.| ALPRAZOLAM TAB 0.25MG.| ATORVASTATIN TAB 80MG.| AYR SALINE GEL NASAL .| BENZONATATE CAP 200MG.| CLOPIDOGREL TAB 75MG.| DEXAMETHASON TAB 4 MG.| ENTRESTO TAB 24-26MG.| FLUTICASONE SPR 50MCG.| FOLIC ACID TAB 1MG.